BCL-xL/BCL2L1 is a critical anti-apoptotic protein that promotes the survival of differentiating pancreatic cells from human pluripotent stem cells
Open Access
- 18 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Disease
- Vol. 11 (5), 1-18
- https://doi.org/10.1038/s41419-020-2589-7
Abstract
The differentiation of human pluripotent stem cells into pancreatic cells involves cellular proliferation and apoptosis during cell fate transitions. However, their implications for establishing cellular identity are unclear. Here, we profiled the expression of BCL-2 family of proteins during pancreatic specification and observed an upregulation of BCL-xL, downregulation of BAK and corresponding downregulation of cleaved CASP3 representative of apoptosis. Experimental inhibition of BCL-xL reciprocally increased apoptosis and resulted in a decreased gene expression of pancreatic markers despite a compensatory increase in anti-apoptotic protein BCL-2. RNA-Seq analyses then revealed a downregulation of multiple metabolic genes upon inhibition of BCL-xL. Follow-up bioenergetics assays revealed broad downregulation of both glycolysis and oxidative phosphorylation when BCL-xL was inhibited. Early perturbation of BCL-xL during pancreatic specification also had subsequent detrimental effects on the formation of INS+ pancreatic beta-like cells. In conclusion, the more differentiated pancreatic progenitors are dependent on anti-apoptotic BCL-xL for survival, whereas the less differentiated pancreatic progenitors that survived after WEHI-539 treatment would exhibit a more immature phenotype. Therefore, modulation of the expression level of BCL-xL can potentially increase the survival and robustness of pancreatic progenitors that ultimately define human pancreatic beta cell mass and function.Keywords
This publication has 33 references indexed in Scilit:
- Sfrp5 Modulates Both Wnt and BMP Signaling and Regulates Gastrointestinal Organogensis in the Zebrafish, Danio rerioPLOS ONE, 2013
- Structure-guided design of a selective BCL-XL inhibitorNature Chemical Biology, 2013
- Human Embryonic Stem Cells Have Constitutively Active Bax at the Golgi and Are Primed to Undergo Rapid ApoptosisMolecular Cell, 2012
- Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potentialThe Journal of cell biology, 2011
- Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthaseNature, 2011
- Overexpression of BCL2 enhances survival of human embryonic stem cells during stress and obviates the requirement for serum factorsProceedings of the National Academy of Sciences of the United States of America, 2011
- Islet β-Cells Deficient in Bcl-xL Develop but Are Abnormally Sensitive to Apoptotic StimuliDiabetes, 2009
- Sfrp5 coordinates foregut specification and morphogenesis by antagonizing both canonical and noncanonical Wnt11 signalingGenes & Development, 2008
- Bak regulates mitochondrial morphology and pathology during apoptosis by interacting with mitofusinsProceedings of the National Academy of Sciences of the United States of America, 2007
- Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and DeathScience, 2001